Business Description
Chempartner Pharmatech Co Ltd
NAICS : 325412
SIC : 2834
ISIN : CNE100000Y27
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.55 | |||||
Equity-to-Asset | 0.61 | |||||
Debt-to-Equity | 0.41 | |||||
Debt-to-EBITDA | -0.61 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 1.03 | |||||
Beneish M-Score | -5.6 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -8.4 | |||||
3-Year FCF Growth Rate | 0.3 | |||||
3-Year Book Growth Rate | -15.6 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 51.26 | |||||
9-Day RSI | 54.89 | |||||
14-Day RSI | 56.3 | |||||
6-1 Month Momentum % | 2.57 | |||||
12-1 Month Momentum % | -44.62 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.71 | |||||
Quick Ratio | 1.66 | |||||
Cash Ratio | 0.88 | |||||
Days Inventory | 14.59 | |||||
Days Sales Outstanding | 91.48 | |||||
Days Payable | 21.8 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | 7.63 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 21.59 | |||||
Operating Margin % | -8.19 | |||||
Net Margin % | -90.73 | |||||
FCF Margin % | 11.49 | |||||
ROE % | -52.86 | |||||
ROA % | -34.01 | |||||
ROIC % | -3.63 | |||||
ROC (Joel Greenblatt) % | -98.5 | |||||
ROCE % | -40.41 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 2.84 | |||||
PB Ratio | 2.24 | |||||
Price-to-Tangible-Book | 2.61 | |||||
Price-to-Free-Cash-Flow | 23.51 | |||||
Price-to-Operating-Cash-Flow | 13.5 | |||||
EV-to-EBIT | -3.53 | |||||
EV-to-EBITDA | -3.53 | |||||
EV-to-Revenue | 3.22 | |||||
EV-to-FCF | 27.41 | |||||
Price-to-Projected-FCF | 2.67 | |||||
Price-to-Median-PS-Value | 0.39 | |||||
Earnings Yield (Greenblatt) % | -28.33 | |||||
FCF Yield % | 3.92 | |||||
Forward Rate of Return (Yacktman) % | 21.38 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Chempartner Pharmatech Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 1,046.076 | ||
EPS (TTM) (Â¥) | -1.906 | ||
Beta | 1.98 | ||
Volatility % | 67.4 | ||
14-Day RSI | 56.3 | ||
14-Day ATR (Â¥) | 0.637902 | ||
20-Day SMA (Â¥) | 5.7585 | ||
12-1 Month Momentum % | -44.62 | ||
52-Week Range (Â¥) | 3.68 - 9.2 | ||
Shares Outstanding (Mil) | 499.78 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Chempartner Pharmatech Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Chempartner Pharmatech Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Chempartner Pharmatech Co Ltd Frequently Asked Questions
What is Chempartner Pharmatech Co Ltd(SZSE:300149)'s stock price today?
When is next earnings date of Chempartner Pharmatech Co Ltd(SZSE:300149)?
Does Chempartner Pharmatech Co Ltd(SZSE:300149) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |